Gliptins

Lancet. 2007 Jan 27;369(9558):269. doi: 10.1016/S0140-6736(07)60135-4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adamantane / adverse effects
  • Adamantane / analogs & derivatives*
  • Adenosine Deaminase / blood
  • Adenosine Deaminase / physiology*
  • Adenosine Deaminase Inhibitors
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dipeptidyl Peptidase 4 / blood
  • Dipeptidyl Peptidase 4 / physiology*
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycoproteins / antagonists & inhibitors
  • Glycoproteins / blood
  • Glycoproteins / physiology*
  • Humans
  • Neuropeptide Y / drug effects
  • Nitriles
  • Pyrrolidines
  • Vildagliptin

Substances

  • Adenosine Deaminase Inhibitors
  • Dipeptidyl-Peptidase IV Inhibitors
  • Glycoproteins
  • Neuropeptide Y
  • Nitriles
  • Pyrrolidines
  • DPP4 protein, human
  • Dipeptidyl Peptidase 4
  • Adenosine Deaminase
  • Vildagliptin
  • Adamantane